Teachers Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History

Teachers Advisors’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$461K	Hold	82,915	–	–	﹤0.01%	2564
2018 Q4	$551K	Hold	82,915	–	–	﹤0.01%	2466
2018 Q3	$885K	Sell	82,915 -759	-0.9%	-$8.7K	﹤0.01%	2369
2018 Q2	$1M	Buy	83,674 +6,485	+8%	+$66.3K	﹤0.01%	2328
2018 Q1	$662K	Hold	77,189	–	–	﹤0.01%	2401
2017 Q4	$763K	Hold	77,189	–	–	﹤0.01%	2367
2017 Q3	$949K	Hold	77,189	–	–	﹤0.01%	2263
2017 Q2	$1.27M	Buy	77,189 +6,077	+9%	+$94.1K	﹤0.01%	2092
2017 Q1	$1.02M	Sell	71,112 -35,778	-33%	-$531K	﹤0.01%	2180
2016 Q4	$1.48M	Buy	106,890 +27,378	+34%	+$439K	﹤0.01%	1958
2016 Q3	$1.44M	Buy	79,512 +11,730	+17%	+$189K	﹤0.01%	1879
2016 Q2	$973K	Buy	67,782 +7,741	+13%	+$105K	﹤0.01%	2050
2016 Q1	$717K	Hold	60,041	–	–	﹤0.01%	2151
2015 Q4	$799K	Hold	60,041	–	–	﹤0.01%	2140
2015 Q3	$645K	Hold	60,041	–	–	﹤0.01%	2235
2015 Q2	$483K	Buy	60,041 +7,507	+14%	+$55.1K	﹤0.01%	2549
2015 Q1	$347K	Buy	52,534 +6,802	+15%	+$46.4K	﹤0.01%	2647
2014 Q4	$291K	Hold	45,732	–	–	﹤0.01%	2732
2014 Q3	$451K	Hold	45,732	–	–	﹤0.01%	2459
2014 Q2	$515K	Sell	45,732 -1,302	-3%	-$14K	﹤0.01%	2409
2014 Q1	$570K	Sell	47,034 -694	-1%	-$8.87K	﹤0.01%	2333
2013 Q4	$601K	Buy	47,728 +3,334	+8%	+$53K	﹤0.01%	2287
2013 Q3	$737K	Buy	44,394 +1,504	+4%	+$25.2K	﹤0.01%	2097
2013 Q2	$651K	Buy	+42,890	New	+$652K	﹤0.01%	2090

Other funds holding LXRX

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Teachers Advisors's LXRX Position: Q1 2019 in Review

Teachers Advisors held its Lexicon Pharmaceuticals (LXRX) position steady in Q1 2019 at 82,915 shares worth $461K. The position accounts for ﹤0.01% of the portfolio, ranked #2564.

Teachers Advisors first reported a position in LXRX in Q2 2013 and has held it in 24 quarters since. The position peaked at $1.48M in Q4 2016. 121 funds tracked by Wall St. Rank hold LXRX as of Q1 2019.

Teachers Advisors held 82,915 shares of Lexicon Pharmaceuticals worth $461K as of Q1 2019.
Teachers Advisors left its Lexicon Pharmaceuticals share count unchanged in Q1 2019.
Lexicon Pharmaceuticals made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2564 holding.
Teachers Advisors first reported a position in Lexicon Pharmaceuticals in Q2 2013 and has held it in 24 quarters since.
Teachers Advisors's Lexicon Pharmaceuticals position peaked at $1.48M in Q4 2016.
121 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.